Manchester
Centre
Manchester ECMC is leading the way in cancer research with an unwavering focus on offering the best treatment options to patients through precision medicine. Our work takes into consideration the complex genetics and evolution of cancer and how this affects the way in which an individual responds to treatments. This...
Interview with Prof Gary Middleton, the new lead of the Birmingham ECMC
News
The new Lead of the Birmingham ECMC talks to us about his career to date, the biggest challenges facing clinical research, and the exciting, unpredictable future for immunotherapy.
Aoife's Corner: Summer 2019: Phase I conference, changes in the Programme Office, and thoughts for the future
News
Aoife Regan gives an update from the summer, discussing about the Phase I: Where Science Becomes Medicine conference, changes in the Programme Office, and her thoughts for the future.
Patient and Public Involvement in the ECMC network
Basic page
All ECMC locations recognise the importance of involving people affected by cancer in their work and the positive impact it can have on the research taking place at their location. Reports showcasing the PPI activities of the adult ECMCs can be found here . The ECMC Programme Office supports the...
Reports showcasing PPI Activities in the ECMC Network
Basic page
Each year the ECMCs provide the ECMC Programme Office with an annual report detailing activity and progress made in the previous financial year. There is a patient and public involvement (PPI) question in the annual report that asks ECMCs to summarise their PPI activity. The responses to this question from...
Interview with Sarah Danson, the new Chair of the Adult Network Strategy Group
News
We speak to Sarah Danson of Sheffield ECMC about her background and her vision for the Adult Network Strategy Group in 2020 and beyond.
Enabling clinicians and researchers to effectively conduct Complex Innovative Design cancer trials
News
A new report, published in the British Journal of Cancer, outlines recommendations for the effective delivery of Complex Innovative Design (CID) trials in the UK and Europe for the first time.
ECMC Programme Office: Meet the new team members
Interview
Over the last couple of months, the ECMC Programme Office has welcomed three new members to their team. Learn more about Dave Ayland, Tara McKay and Xi Ye as we find out about their role in the team, their previous experience and their main highlight since joining. What is your...
Understanding the impact of COVID on cancer patients
News
Technicians, admin staff, QA managers and various pieces of equipment in the Liverpool ECMC have been re-deployed to support the UK Clinical Characterisation protocol, part of ISARIC-4C.
Repurposing, novel drugs and methods to stop transmission in the fight against COVID-19
News
Southampton hosts a NIHR Biomedical Research Centre (BRC) with a focus on respiratory disease and our CRUK Clinical Trial Unit (CTU) there has also previously developed some non-cancer lung studies as it is also a NIHR CTU support funded CTU. Southampton CTU has been contributing its CRUK/NIHR staff expertise in study design, development and/or delivery of a number of COVID-19 trials